Brief: Cizzle Biotechnology Signs Heads Of Terms To Partner With CorePath
May 6 (Reuters) - Cizzle Biotechnology Holdings PLC CIZ.L :
* CIZZLE BIOTECHNOLOGY - STRATEGIC ALLIANCE RE LUNG CANCER
DETECTION IN USA
* CIZZLE BIOTECHNOLOGY - SIGNED HEADS OF TERMS TO PARTNER
WITH
COREPATH TO DEVELOP, OFFER ITS PROPRIETARY EARLY-STAGE LUNG
CANCER TEST THROUGHOUT USA
Source text for Eikon: ID:nRSF5257Ka
Further company coverage: CIZ.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cizzle Biotechnology Holdings
See all newsRCS - Cizzle Biotechnology - Cizzle Shortlisted for One Nucleus Award 2026
Brief: Cizzle Biotechnology and Cizzle Bio Achieve CLIA Validation
Cizzle Biotechnology - Update on Launch of Lung Cancer Test in USA
Cizzle Biotechnology - Interim Results
Cizzle Biotechnology - Laboratory Expansion to Accelerate Sales in USA